Ritesh Agarwal, the founder of OYO, has invested ₹830 crore in the company through his Singapore-based entity, Patient Capital, as part of the latest funding round. This investment is part of OYO's recent capital raise of ₹1,457 crore from a group of investors, as confirmed by insiders.

Following this Series G funding round, Agarwal's ownership in OYO will increase from 29.97% to 32.57%. Sources indicate that Agarwal's move is both a strategic effort to maintain his stake in the company and a demonstration of his confidence in OYO's future. The funds supporting this investment are said to come from Singapore-based family offices.

Oravel Stays Ltd, OYO's parent company, secured the additional ₹1,457 crore from a consortium of investors, with the fundraising initiative receiving near-unanimous approval—99.99%—from shareholders during an Extraordinary General Meeting (EGM) held on August 8.

This latest capital infusion values OYO at $2.4 billion, aligning with the valuation set during the first tranche of the Series G round issued to InCred in July. The funds are being raised through the issuance of Compulsory Convertible Cumulative Preference Shares, each priced at ₹29, consistent with the recent valuation.

The newly acquired capital will be directed towards supporting OYO's growth and fueling its global expansion strategy, according to sources familiar with the company's plans.